Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Int J Biol Sci. 2022 Jan 1;18(2):459-472. doi: 10.7150/ijbs.59272. eCollection 2022.

Abstract

The COVID-19 outbreak is emerging as a significant public health challenge. Excessive production of proinflammatory cytokines, also known as cytokine storm, is a severe clinical syndrome known to develop as a complication of infectious or inflammatory diseases. Clinical evidence suggests that the occurrence of cytokine storm in severe acute respiratory syndrome secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is closely associated with the rapid deterioration and high mortality of severe cases. In this review, we aim to summarize the mechanism of SARS-CoV-2 infection and the subsequent immunological events related to excessive cytokine production and inflammatory responses associated with ACE2-AngII signaling. An overview of the diagnosis and an update on current therapeutic regimens and vaccinations is also provided.

Keywords: COVID-19; SARS-CoV-2; cytokine storm; cytokines; diagnosis; immune response; therapy; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / pathology*
  • Cytokine Release Syndrome / etiology*
  • Cytokine Release Syndrome / immunology
  • Cytokine Release Syndrome / pathology*
  • Cytokine Release Syndrome / therapy
  • Cytokines / genetics
  • Cytokines / metabolism
  • Gene Expression Regulation / immunology
  • Humans
  • SARS-CoV-2*

Substances

  • Cytokines